{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "The EU-UK Agreement and the implications for life sciences companies",
    "url": "https://www.lexblog.com/2020/12/30/the-eu-uk-agreement-and-the-implications-for-life-sciences-companies/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-R1GAHCVV",
        "url": "https://www.lexblog.com/lib/R1GAHCVV/"
    },
    "datePublished": "2020-12-30T12:43:29-05:00",
    "dateModified": "2021-10-26T12:36:37-04:00",
    "author": {
        "@type": "Person",
        "name": "Lincoln Tsang, Arnold & Porter, Ian Dodds-Smith"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Arnold & Porter Kaye Scholer LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "BioSlice Blog",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.biosliceblog.com/?p=2967",
    "sourceStability": "may-move"
}